###begin article-title 0
###xml 53 73 53 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Enterococcus faecium</italic>
###xml 53 73 <span type="species:ncbi:1352">Enterococcus faecium</span>
RNase 7 Contributes to the Cutaneous Defense against Enterococcus faecium
###end article-title 0
###begin p 1
Conceived and designed the experiments: BK MS RG RP JMS JH. Performed the experiments: BK MS RG. Analyzed the data: BK MS RG RP JMS JH. Contributed reagents/materials/analysis tools: JMS JH. Wrote the paper: JH.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 198 218 <span type="species:ncbi:1352">Enterococcus faecium</span>
###xml 331 341 <span type="species:ncbi:1352">E. faecium</span>
Human skin is able to mount a fast response against invading microorganisms by the release of antimicrobial proteins such as the ribonuclease RNase 7. Because RNase 7 exhibits high activity against Enterococcus faecium the aim of this study was to further explore the role of RNase 7 in the cutaneous innate defense system against E. faecium.
###end p 3
###begin title 4
Methodology/Principal Findings
###end title 4
###begin p 5
###xml 402 412 <span type="species:ncbi:1352">E. faecium</span>
###xml 514 524 <span type="species:ncbi:1352">E. faecium</span>
###xml 687 697 <span type="species:ncbi:1352">E. faecium</span>
###xml 750 760 <span type="species:ncbi:1352">E. faecium</span>
###xml 962 972 <span type="species:ncbi:1352">E. faecium</span>
Absolute quantification using real-time PCR and ELISA revealed that primary keratinocytes expressed high levels of RNase 7. Immunohistochemistry showed RNase 7 expression in all epidermal layers of the skin with an intensification in the upper more differentiated layers. Furthermore, RNase 7 was secreted by keratinocytes in vitro and in vivo in a site-dependent way. RNase 7 was still active against E. faecium at low pH (5.5) or high NaCl (150 mM) concentration and the bactericidal activity of RNase 7 against E. faecium required no ribonuclease activity as shown by recombinant RNase 7 lacking enzymatic activity. To further explore the role of RNase 7 in cutaneous defense against E. faecium, we investigated whether RNase 7 contributes to the E. faecium killing activity of skin extracts derived from stratum corneum. Treatment of the skin extract with an RNase 7 specific antibody, which neutralizes the antimicrobial activity of RNase 7, diminished its E. faecium killing activity.
###end p 5
###begin title 6
Conclusions/Significance
###end title 6
###begin p 7
###xml 50 60 <span type="species:ncbi:1352">E. faecium</span>
###xml 158 163 <span type="species:ncbi:9606">human</span>
###xml 177 187 <span type="species:ncbi:1352">E. faecium</span>
Our data indicate that RNase 7 contributes to the E. faecium-killing activity of skin extracts and suggest an important role for RNase 7 in the protection of human skin against E. faecium colonization.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 322 325 322 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Braff1">[1]</xref>
###xml 326 329 326 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Schrder1">[3]</xref>
###xml 491 498 491 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 632 635 632 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Chromek1">[4]</xref>
###xml 636 639 636 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Salzman1">[6]</xref>
###xml 825 828 825 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Schrder1">[3]</xref>
###xml 830 833 830 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-DeSmet1">[7]</xref>
###xml 834 837 834 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Zanetti1">[9]</xref>
###xml 971 975 971 975 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Zanetti2">[10]</xref>
###xml 976 980 976 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Harder2">[17]</xref>
###xml 1090 1094 1090 1094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Glser1">[18]</xref>
###xml 1159 1166 1159 1166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 1313 1320 1313 1320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 1320 1324 1320 1324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Glser1">[18]</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 110 115 <span type="species:ncbi:9606">human</span>
###xml 193 198 <span type="species:ncbi:9606">human</span>
###xml 745 750 <span type="species:ncbi:9606">human</span>
###xml 1159 1166 <span type="species:ncbi:562">E. coli</span>
###xml 1246 1251 <span type="species:ncbi:9606">human</span>
###xml 1313 1320 <span type="species:ncbi:562">E. coli</span>
Human skin is continuously exposed to a wide variety of potential pathogenic bacteria. Despite these threats, human skin is normally not infected. In the last decade it has become evident that human skin provides, in addition to its physical barrier, also a chemical barrier based on the release of antimicrobial proteins [1]-[3]. Antimicrobial proteins are endogenous, gene-encoded proteins, which are able to kill bacteria, fungi and viruses at micro- and nanomolar concentrations. Recent in vivo studies confirmed the hypothesis that antimicrobial proteins have the capacity to protect the host against pathogenic microorganisms [4]-[6]. Some of these antimicrobial proteins are upregulated at sites of infection and inflammation such as the human beta-defensins -2 and -3 (hBD-2, hBD-3) as well as the cathelicidin LL-37 [3], [7]-[9]. Upregulation of hBD-2, hBD-3 and LL-37 in the skin provides a rapid first-line of cutaneous defense against invading microorganisms [10]-[17]. Other antimicrobial proteins such as psoriasin (S100 A7) are also expressed in high amounts in healthy skin [18]. Psoriasin is mainly active against the gram-negative bacterium E. coli and we recently presented evidence that psoriasin is key for the resistance of human skin against colonization by the gram-negative gut bacterium E. coli[18].
###end p 9
###begin p 10
###xml 176 180 176 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Dyer1">[19]</xref>
###xml 348 352 348 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Dyer1">[19]</xref>
###xml 580 584 580 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Dyer1">[19]</xref>
###xml 920 924 920 924 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Domachowske1">[20]</xref>
###xml 926 930 926 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Domachowske2">[21]</xref>
###xml 958 966 958 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1041 1045 1041 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Lehrer1">[22]</xref>
###xml 1113 1117 1113 1117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Hooper1">[23]</xref>
###xml 1209 1213 1209 1213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Fett1">[24]</xref>
###xml 1307 1311 1307 1311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Harder3">[25]</xref>
###xml 1369 1373 1369 1373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Harder3">[25]</xref>
###xml 1381 1386 1381 1386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1443 1447 1443 1447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Zhang1">[26]</xref>
###xml 1594 1598 1594 1598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Harder3">[25]</xref>
###xml 1600 1604 1600 1604 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Glser2">[27]</xref>
###xml 1732 1736 1732 1736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Gambichler1">[28]</xref>
###xml 154 160 <span type="species:ncbi:9913">bovine</span>
###xml 369 374 <span type="species:ncbi:9606">human</span>
###xml 482 487 <span type="species:ncbi:9606">human</span>
###xml 1723 1731 <span type="species:ncbi:9606">patients</span>
Another antimicrobial protein expressed in healthy skin is RNase 7. RNase 7 is a member of the RNase A superfamily that is characterized by homology with bovine ribonuclease A [19]. Members of this family share a conserved structure of six or eight cysteines linked by disulfide bonds and two histidines and one lysine that form the catalytic site [19]. To date, eight human members (RNase 1-8) of the RNase A superfamily have been described. Moreover, five additional genes in the human genome that are related to the RNase A ribonucleases have also been identified (RNase 9-13) [19]. However, the physiological role of these ribonucleases is still not well understood. Recent data suggest that ribonucleases may also play a role in host defense. Eosinophil-derived neurotoxin (EDN; RNase 2) and eosinophil cationic protein (ECP; RNase 3) are localized to eosinophil secretory granules and exhibit antiviral activities [20], [21]. In addition, ECP displays in vitro killing activity against various gram-negative and gram-positive bacteria [22]. Antimicrobial activity was also reported for RNase 5 (Angiogenin) [23], a protein which was originally identified from its capacity to induce blood vessel growth [24]. RNase 7 was originally isolated from stratum corneum extracts and cloned from keratinocytes [25]. It exhibited a broad-spectrum of antimicrobial activity [25]. Zhang et al. isolated the RNase 7 gene by a genomic database search [26]. RNase 7 mRNA expression was detected in primary keratinocytes and expression was induced by contact with heat-killed bacteria and UV-B radiation [25], [27]. Recently, induction of RNase 7 mRNA expression has been reported in skin biopsies of psoriasis and atopic dermatitis patients [28].
###end p 10
###begin p 11
###xml 113 121 113 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 133 140 133 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 369 379 369 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. faecium</italic>
###xml 300 305 <span type="species:ncbi:9606">human</span>
###xml 369 379 <span type="species:ncbi:1352">E. faecium</span>
The aim of this study was to further assess the role of RNase 7 in cutaneous defense. A detailed analysis of its in vitro as well as in vivo expression together with functional antimicrobial studies suggest that RNase 7 may play a major role in skin defense and contributes to the high resistance of human skin against colonization with the gram-positive gut bacterium E. faecium.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
Generation of RNase 7-specific antibodies
###end title 13
###begin p 14
###xml 64 71 64 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 401 408 401 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006424-g001">Fig. 1A</xref>
###xml 478 485 478 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 636 643 636 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006424-g001">Fig. 1B</xref>
###xml 793 795 793 795 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 987 991 987 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Rudolph1">[29]</xref>
###xml 64 71 <span type="species:ncbi:562">E. coli</span>
###xml 88 92 <span type="species:ncbi:9925">goat</span>
First, we successfully expressed RNase 7 in recombinant form in E. coli. The serum of a goat immunized by a mixture of natural and recombinant RNase 7 showed high RNase 7 immunoreactivity. Purification of RNase 7 antibodies from the serum using an RNase 7 affinity column led to the isolation of RNase 7 specific antibodies. These antibodies specifically detected RNase 7 in stratum corneum extracts (Fig. 1A). For quantitative analyses and to determine how RNase 7 is secreted in vivo at different skin sites, we developed an RNase 7-specific enzyme-linked immunosorbent assay (ELISA) using the RNase 7-specific polyclonal antibodies. Fig. 1B shows a representative standard curve using different concentrations of RNase 7. The detection limit of the ELISA was at a concentration of 0.3 ng⋅ml-1. The specificity of the RNase 7 antibodies was further verified by testing other cationic antimicrobial proteins such as lysozyme, hBD-2, hBD-3 and the closely related (78% identity) RNase 8 [29]. All these proteins were not detected by the RNase 7 ELISA (not shown).
###end p 14
###begin title 15
Generation of RNase 7 specific antibodies and ELISA.
###end title 15
###begin p 16
###xml 708 710 704 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 6 10 <span type="species:ncbi:9925">goat</span>
(A) A goat was immunized with a combination of natural and recombinant RNase 7, and serum was purified with an RNase 7 affinity column. The specificity of the RNase 7 affinity-purified polyclonal antibodies was verified by Western-Blot analysis. 100 microg of stratum corneum extract and different amounts of natural skin-derived RNase 7 and recombinant RNase 7 were subjected to Western-Blot analysis using the affinity-purified polyclonal antibodies raised against RNase 7. (B) The RNase 7 antibodies were used to establish an ELISA as described in the experimental procedures. A representative standard curve of the RNase 7 ELISA is shown. The detection limit of the ELISA was a concentration of 0.3 ng⋅ml-1 RNase 7.
###end p 16
###begin title 17
Primary keratinocytes express high levels of RNase 7 mRNA
###end title 17
###begin p 18
###xml 312 319 312 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006424-g002">Fig. 2A</xref>
###xml 260 265 <span type="species:ncbi:9606">human</span>
We used real-time PCR to determine the absolute transcript levels in primary keratinocytes. This quantitative analysis revealed that primary keratinocytes expressed high levels of RNase 7 mRNA when compared to other skin-derived antimicrobial proteins such as human beta-defensin-2 (hBD-2), psoriasin and LL-37 (Fig. 2A).
###end p 18
###begin title 19
Abundant expression and secretion of RNase 7 in primary keratinocytes.
###end title 19
###begin p 20
(A) Transcript levels quantified by real-time PCR of various antimicrobial proteins expressed in primary keratinocytes. Shown is the range of data obtained in three independent experiments measured in triplicate. (B) Secretion of antimicrobial proteins from keratinocytes cultured for 16 h. Supernatants of primary keratinocytes were analyzed for RNase 7, psoriasin and hBD-2 by ELISA. Shown is the range of data obtained by three independent experiments measured in triplicate. (C) Comparison of RNase 7 protein present in cell extracts with supernatants from primary keratinocytes cultured for 16 h. Shown are the results of three independent cell culture samples (columns represent means+/-S.D.).
###end p 20
###begin title 21
###xml 20 28 20 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 33 40 33 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
RNase 7 is secreted in vitro and in vivo
###end title 21
###begin p 22
###xml 164 165 164 165 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 331 338 331 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006424-g002">Fig. 2B</xref>
###xml 517 524 517 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006424-g002">Fig. 2C</xref>
###xml 568 575 568 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 677 678 677 678 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 1043 1045 1039 1041 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 1047 1053 1043 1049 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006424-g003">Fig. 3</xref>
###xml 1228 1230 1224 1226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 701 706 <span type="species:ncbi:9606">human</span>
To study whether RNase 7 is secreted by keratinocytes, we analyzed keratinocyte culture supernatants as well as cell extracts by ELISA. High amounts (3-18 ng/1.5x105 cells) of RNase 7 were detected in the supernatants of primary keratinocytes cultured for 16 h indicating that RNase 7 is efficiently secreted by the keratinocytes (Fig. 2B). A comparison of RNase 7 amounts present in the culture supernatants and cell extracts derived from primary keratinocytes revealed that the main portion of RNase 7 is released (Fig. 2C). To determine whether RNase 7 is secreted in vivo, we investigated the presence of RNase 7 at various skin surface sites. We rinsed standardized 0.5-cm2 skin areas of healthy human donors with 500 microl 10 mM sodium phosphate buffer containing 150 mM NaCl, pH 7.4 and analyzed the washing fluids for their content of RNase 7 by ELISA. RNase 7 amounts at skin surfaces depended on the donor (n = 10), the skin area, and previous washings for body care. RNase 7 amounts were mainly in the range between 0.3 and 3 ng⋅cm-2 (Fig. 3). In addition, we investigated the concentration of RNase 7 in perianal swabs derived from six individuals. In all six samples RNase 7 was detectable (range of 3.9-12.2 ng⋅ml-1; not shown).
###end p 22
###begin title 23
###xml 20 27 20 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
RNase 7 is secreted in vivo on the body surface.
###end title 23
###begin p 24
###xml 272 273 272 273 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Standardized areas of various body locations on healthy volunteers (n = 10) were rinsed with 10 mM sodium phosphate buffer containing 150 mM NaCl, pH 7.4 to determine the concentration of RNase 7 at the skin surface by ELISA. Data represent the amount of soluble RNase7/cm2. Each symbol represents data from a single volunteer.
###end p 24
###begin title 25
###xml 48 53 <span type="species:ncbi:9606">human</span>
RNase 7 is expressed in all epidermal layers of human skin
###end title 25
###begin p 26
###xml 59 66 59 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 503 509 503 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006424-g004">Fig. 4</xref>
To investigate the distribution of RNase 7 in healthy skin in vivo, we performed immunohistochemistry using the RNase 7-specific antibodies. Intense RNase 7 immunoreactivity was present in all epidermal layers of the skin with an intensification of the upper more differentiated layers, especially within stratum corneum. Sebaeceous glands and hair follicles also stained positively. The outer root sheath of hair follicles showed more intensive immunoreactivity when compared to the inner root sheath (Fig. 4).
###end p 26
###begin title 27
###xml 40 47 40 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Epidermal keratinocytes express RNase 7 in vivo.
###end title 27
###begin p 28
###xml 48 53 <span type="species:ncbi:9606">human</span>
(A & B) Immunostaining of RNase 7 expression in human normal skin using affinity-purified RNase 7 antibodies. Strong RNase 7 immunoreactivity was detected in the epidermis with highest activity in the uppermost epidermal layers. Sebaecous glands and hair follicles also stained positively. (A) 10xmagnification, (B) 20 X magnification of the indicated area of panel A. (C) Negative control using preimmune serum. (E: Epidermis, SC: Stratum Corneum, HF: Hair Follicle, I: Infundibulum, SG: Sebaceous Gland, DP: Dermal Papilla, ORS: Outer Root Sheath, IRS: Inner Root Sheath)
###end p 28
###begin title 29
###xml 66 76 66 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. faecium</italic>
###xml 66 76 <span type="species:ncbi:1352">E. faecium</span>
Characterization of the antimicrobial activity of RNase 7 against E. faecium
###end title 29
###begin p 30
###xml 56 66 56 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. faecium</italic>
###xml 174 184 174 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. faecium</italic>
###xml 267 269 267 269 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">90</sub>
###xml 290 292 286 288 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 523 529 519 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006424-g005">Fig. 5</xref>
###xml 545 555 541 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. faecium</italic>
###xml 611 617 607 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006424-g005">Fig. 5</xref>
###xml 56 66 <span type="species:ncbi:1352">E. faecium</span>
###xml 174 184 <span type="species:ncbi:1352">E. faecium</span>
###xml 545 555 <span type="species:ncbi:1352">E. faecium</span>
To verify the antimicrobial activity of RNase 7 against E. faecium, we investigated natural RNase 7 for microbicidal activity in an antimicrobial microdilution assay against E. faecium (ATCC 6057). This strain was effectively killed by RNase 7 (lethal dose of 90% (LD90) = 0.4-0.8 microg⋅ml-1; not shown). To further support the idea of an antimicrobial function for RNase 7 in cutaneous defense, we performed antimicrobial assays in buffers with variable pH (5.5, 6.5 and 7.4). RNase 7 was active under all pH conditions (Fig. 5). In addition, E. faecium was also effectively killed by RNase 7 at 150 mM NaCl (Fig. 5).
###end p 30
###begin title 31
###xml 42 52 42 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. faecium</italic>
###xml 42 52 <span type="species:ncbi:1352">E. faecium</span>
Antimicrobial activity of RNase 7 against E. faecium at various pH and high salt conditions.
###end title 31
###begin p 32
###xml 52 54 48 50 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 100 110 96 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. faecium</italic>
###xml 100 110 <span type="species:ncbi:1352">E. faecium</span>
The antimicrobial activity of RNase 7 (1.6 microg⋅ml-1) was tested in a microdilution assay against E. faecium (ATCC 6057) at various pH conditions or in the presence of 150 mM NaCl. Results are from triplicate determinations and presented as the mean+/-S.D.
###end p 32
###begin title 33
###xml 32 42 32 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. faecium</italic>
###xml 32 42 <span type="species:ncbi:1352">E. faecium</span>
The activity of RNase 7 against E. faecium requires no enzymatic activity
###end title 33
###begin p 34
###xml 240 247 240 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006424-g006">Fig. 6A</xref>
###xml 405 415 405 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. faecium</italic>
###xml 605 612 605 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006424-g006">Fig. 6B</xref>
###xml 650 657 650 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 405 415 <span type="species:ncbi:1352">E. faecium</span>
###xml 650 657 <span type="species:ncbi:562">E. coli</span>
To assess whether the ribonuclease activity of RNase 7 might be responsible for its antibacterial activity, we expressed recombinant RNase 7 containing two mutated amino acids in its active site required for enzymatic activity. As shown in Fig. 6A, mutated RNase 7 exhibited no ribonuclease activity whereas the recombinant wildtype RNase 7 showed high ribonuclease activity. However, when tested against E. faecium, no differences in the killing activity of wildtype and mutated RNase 7 were observed, suggesting that the ribonuclease activity of RNase 7 is not necessary for its antibacterial activity (Fig. 6B). Similar results were obtained with E. coli (not shown).
###end p 34
###begin title 35
Bactericidal activity of RNase 7 requires no enzymatic activity.
###end title 35
###begin p 36
###xml 411 413 407 409 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 422 432 418 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. faecium</italic>
###xml 422 432 <span type="species:ncbi:1352">E. faecium</span>
(A) Shown are the ribonuclease activities of wildtype non-mutated recombinant RNase 7 (wt R7) and mutated recombinant RNase 7 containing the double mutation, histidin-123 to aspartate and lysine-38 to arginine (mut R7). n.d. = not detectable. (B) The antimicrobial activity of wildtype recombinant RNase 7 (wt R7) and ribonuclease-deficient RNase 7 (mut R7) were tested at concentrations of 20 and 1.5 microg⋅ml-1 against E. faecium (ATCC 6057). Data are means+/-S.D.
###end p 36
###begin title 37
###xml 47 52 <span type="species:ncbi:9606">human</span>
###xml 86 96 <span type="species:ncbi:1352">E. faecium</span>
RNase 7 contributes to the killing activity of human stratum corneum extracts against E. faecium and faecalis
###end title 37
###begin p 38
###xml 46 58 46 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Enterococcus</italic>
###xml 161 171 161 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. faecium</italic>
###xml 323 333 323 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. faecium</italic>
###xml 394 404 394 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. faecium</italic>
###xml 484 491 484 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006424-g007">Fig. 7A</xref>
###xml 564 574 564 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. faecium</italic>
###xml 1091 1101 1091 1101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. faecium</italic>
###xml 1140 1150 1140 1150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. faecium</italic>
###xml 1159 1166 1159 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006424-g007">Fig. 7B</xref>
###xml 161 171 <span type="species:ncbi:1352">E. faecium</span>
###xml 323 333 <span type="species:ncbi:1352">E. faecium</span>
###xml 394 404 <span type="species:ncbi:1352">E. faecium</span>
###xml 564 574 <span type="species:ncbi:1352">E. faecium</span>
###xml 726 730 <span type="species:ncbi:9925">goat</span>
###xml 949 954 <span type="species:ncbi:9606">human</span>
###xml 1091 1101 <span type="species:ncbi:1352">E. faecium</span>
###xml 1140 1150 <span type="species:ncbi:1352">E. faecium</span>
To analyze whether RNase 7 contributes to the Enterococcus-killing activity of healthy skin, we determined whether antibodies to RNase 7 affected the killing of E. faecium in skin extracts derived from stratum corneum. First, we analyzed whether RNase 7 antibodies neutralized the antibacterial activity of RNase 7 against E. faecium. For this purpose we tested the activity of RNase 7 against E. faecium in an antibacterial microdilution assay in the presence of RNase 7 antibodies. Fig. 7A shows that application of the RNase 7 antibodies completely blocked the E. faecium-killing activity of RNase 7. Antimicrobial activity was not inhibited when equivalent concentrations of irrelevant antibodies (antibodies derived from goat preimmune serum) were used. Having established that the RNase 7-specific antibodies neutralized the antimicrobial effect of RNase 7, we used this approach to investigate the role of RNase 7 for the killing activity of human skin extracts. The application of the RNase 7-blocking antibodies to skin extracts derived from stratum corneum before inoculation with E. faecium resulted in a substantial increase in E. faecium growth (Fig. 7B).
###end p 38
###begin title 39
###xml 86 96 86 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. faecium</italic>
###xml 47 52 <span type="species:ncbi:9606">human</span>
###xml 86 96 <span type="species:ncbi:1352">E. faecium</span>
RNase 7 contributes to the killing activity of human stratum corneum extracts against E. faecium.
###end title 39
###begin p 40
###xml 27 29 23 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 75 85 71 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. faecium</italic>
###xml 139 141 135 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 234 244 230 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. faecium</italic>
###xml 475 485 471 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. faecium</italic>
###xml 566 576 562 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. faecium</italic>
###xml 607 617 603 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. faecium</italic>
###xml 701 711 697 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. faecium</italic>
###xml 910 911 906 907 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 75 85 <span type="species:ncbi:1352">E. faecium</span>
###xml 234 244 <span type="species:ncbi:1352">E. faecium</span>
###xml 326 330 <span type="species:ncbi:9925">goat</span>
###xml 475 485 <span type="species:ncbi:1352">E. faecium</span>
###xml 566 576 <span type="species:ncbi:1352">E. faecium</span>
###xml 607 617 <span type="species:ncbi:1352">E. faecium</span>
###xml 701 711 <span type="species:ncbi:1352">E. faecium</span>
(A) RNase 7 (12.5 microg⋅ml-1) was tested in a microdilution assay against E. faecium (ATCC 6057) alone (R7) or in the presence of 10 mg⋅ml-1 RNase 7 antibodies (R7+R7-Ab). Application of the RNase 7 antibodies completely blocked the E. faecium-killing activity of RNase 7. As a control, RNase 7 was incubated with irrelevant goat antibodies (R7+irr.Ab). Both, RNase 7 antibodies (R7-Ab) alone as well as irrelevant antibodies (irr. Ab) alone did not influence the growth of E. faecium. (B) The killing activity of skin-extracts derived from stratum corneum against E. faecium was tested. 2 h incubation of E. faecium with stratum corneum extract revealed high killing activity of the extract against E. faecium (s.c.). In contrast, the application of RNase 7-blocking antibodies to the stratum corneum extract significantly reduced the killing activity of the extract (s.c.+ R7-specific Ab; p<0.01, Student's t-test). Incubation of the stratum corneum extract with the irrelevant antibodies did not affect the killing activity of the extracts (s.c.+ irrelevant Ab). Data show means+/-S.D. of triplicate samples. A representative result of three independent experiments is shown.
###end p 40
###begin title 41
Discussion
###end title 41
###begin p 42
###xml 324 327 324 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Braff1">[1]</xref>
###xml 329 332 329 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Schrder1">[3]</xref>
###xml 564 568 564 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Rosenberg1">[30]</xref>
###xml 570 574 570 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Rosenberg2">[31]</xref>
###xml 759 763 759 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Hooper1">[23]</xref>
###xml 202 207 <span type="species:ncbi:9606">human</span>
###xml 376 381 <span type="species:ncbi:9606">human</span>
###xml 669 674 <span type="species:ncbi:10090">mouse</span>
There is increasing evidence that the skin and other epithelial layers are protected from infection by the release of antimicrobial proteins. Many studies indicate that antimicrobial proteins, like the human beta-defensins, cathelicidin LL-37 and S100 protein psoriasin (S100A7), play an important role in cutaneous defense [1], [3]. Although several reports suggest that the human RNase A superfamily members ECP (eosinophil cationic protein, RNase 3) and EDN (eosinophil-derived neurotoxin, RNase 2) are important effector molecules of eosinophilic granulocytes [30], [31], the role of RNases in epithelial defense is largely unknown. A recent study indicates that a mouse ribonuclease (angiogenin 4) may participate in regulating the intestinal microflora [23].
###end p 42
###begin p 43
###xml 917 921 917 921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Reithmayer1">[32]</xref>
###xml 683 688 <span type="species:ncbi:9606">human</span>
The recent isolation of the antimicrobial ribonuclease RNase 7 from stratum corneum of healthy skin prompted us to further analyze its role in cutaneous defense. A quantitative analysis revealed that primary keratinocytes express high levels of RNase 7 mRNA when compared to other skin-derived antimicrobial proteins such as psoriasin, hBD-2, and LL-37. This observation further strengthened the hypothesis that RNase 7 may be an important defense molecule in cutaneous innate immunity. To get further insight into RNase 7 protein expression, we generated RNase 7 specific antibodies. Immunohistochemistry using these novel antibodies revealed expression of RNase 7 in all layers of human epidermis with higher intensity in the more outer differentiated epithelial layers. Hair follicles also stained positively which is in concordance with a recent study demonstrating RNase 7 expression in hair follicle epithelium [32]. The expression of RNase 7 in the uppermost epidermal layers and its expression in hair follicles are in concordance with its proposed antimicrobial function, because it is expressed at areas where the first contact with bacteria takes place. Because the deduced RNase 7 precursor contains a signal sequence, we hypothesized that RNase 7 may be efficiently secreted by keratinocytes. Using an RNase 7-ELISA, that we developed, we were able to detect higher RNase 7 protein levels in the supernatants of the primary keratinocyte cultures compared with keratinocyte extracts. These data indicate that RNase 7 is secreted from viable cells and acts primarily outside the cell, which is consistent with the proposed role of RNase 7 in antimicrobial defense.
###end p 43
###begin p 44
###xml 15 23 15 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 69 76 69 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 338 345 338 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 418 425 <span type="species:ncbi:9606">persons</span>
Based on these in vitro data, we speculated that RNase 7 is secreted in vivo on the body surface. To prove this hypothesis, we determined whether RNase 7 is present at various skin surface sites. We were able to recover various amounts of RNase 7 in skin washing fluids from different body sites, which confirmed that RNase 7 is secreted in vivo. High variability in RNase 7 secretion levels was detected in different persons and skin locations. This suggests that levels of RNase 7 secretion may depend on environmental factors such as microbial colonization.
###end p 44
###begin p 45
###xml 48 55 48 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 133 140 133 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 140 144 140 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Glser1">[18]</xref>
###xml 231 241 231 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. faecium</italic>
###xml 241 245 241 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Harder3">[25]</xref>
###xml 312 322 312 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. faecium</italic>
###xml 391 401 391 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. faecium</italic>
###xml 517 527 517 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. faecium</italic>
###xml 595 605 595 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. faecium</italic>
###xml 700 710 700 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. faecium</italic>
###xml 973 983 973 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. faecium</italic>
###xml 1091 1101 1091 1101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. faecium</italic>
###xml 48 55 <span type="species:ncbi:562">E. coli</span>
###xml 133 140 <span type="species:ncbi:562">E. coli</span>
###xml 231 241 <span type="species:ncbi:1352">E. faecium</span>
###xml 312 322 <span type="species:ncbi:1352">E. faecium</span>
###xml 391 401 <span type="species:ncbi:1352">E. faecium</span>
###xml 517 527 <span type="species:ncbi:1352">E. faecium</span>
###xml 595 605 <span type="species:ncbi:1352">E. faecium</span>
###xml 700 710 <span type="species:ncbi:1352">E. faecium</span>
###xml 973 983 <span type="species:ncbi:1352">E. faecium</span>
###xml 1091 1101 <span type="species:ncbi:1352">E. faecium</span>
We recently identified psoriasin as a principal E. coli-killing factor that protects the skin from infections with the gut bacterium E. coli[18]. However, the high expression of RNase 7 in skin and its very potent activity against E. faecium[25] suggest that the skin is also protected against colonization with E. faecium. This would explain the low infection rate of skin areas exposed to E. faecium such as the perianal region. To prove this hypothesis, we first explored whether the skin has the capacity to kill E. faecium. Skin extracts derived from the stratum corneum efficiently killed E. faecium indicating that the skin harbors defense mechanisms which inhibit cutaneous colonization with E. faecium. To further evaluate whether RNase 7 might contribute to these defense mechanisms, we specifically inhibited the antimicrobial activity of RNase 7 in the skin extracts using RNase 7-specific antibodies. These experiments revealed that RNase 7 contributes to the E. faecium killing activity of skin extracts, suggesting an important role for RNase 7 in protecting the skin against E. faecium infection.
###end p 45
###begin p 46
###xml 51 61 51 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. faecium</italic>
###xml 245 255 245 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. faecium</italic>
###xml 529 539 529 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. faecium</italic>
###xml 683 687 683 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Rosenberg3">[33]</xref>
###xml 688 692 688 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Nitto1">[35]</xref>
###xml 913 917 913 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Domachowske1">[20]</xref>
###xml 919 923 919 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Domachowske2">[21]</xref>
###xml 51 61 <span type="species:ncbi:1352">E. faecium</span>
###xml 245 255 <span type="species:ncbi:1352">E. faecium</span>
###xml 529 539 <span type="species:ncbi:1352">E. faecium</span>
###xml 837 864 <span type="species:ncbi:12814">respiratory syncytial virus</span>
###xml 866 869 <span type="species:ncbi:12814?0.7497633322814768">RSV</span>
The high antimicrobial activity of RNase 7 against E. faecium raises the question of the responsible molecular killing mechanisms. We speculated that the high ribonuclease activity of RNase 7 might be involved in the RNase 7-mediated killing of E. faecium. To address this question, we generated recombinant RNase 7 that lacks enzymatic activity. By making point mutations of the catalytic residues lys-38 and his-123, we found that ablation of ribonuclease activity had no impact on the bactericidal activity of RNase 7 against E. faecium. This is consistent with other reports showing that members of the RNase A superfamily exhibit ribonuclease-independent antibacterial activity [33]-[35], but raises the question of the role of the enzymatic activity. It has been shown that the antiviral activity of the RNases ECP and EDN against respiratory syncytial virus (RSV) requires functional ribonuclease activity [20], [21]. These data suggest that the ribonuclease activity of RNase 7 may be necessary for a potential antiviral rather than antibacterial activity. However, this remains to be proven as it is not yet known whether RNase 7 exhibits antiviral activity.
###end p 46
###begin p 47
###xml 148 152 148 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Abtin1">[36]</xref>
###xml 487 491 487 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Johnson1">[37]</xref>
Recently, it has been reported that the ribonuclease inhibitor interacts with RNase 7 and blocks its ribonuclease as well as antimicrobial activity [36]. It is possible that the ribonuclease inhibitor masks the amino acid residues responsible for the antimicrobial action of RNase 7. Another explanation is that the interaction of the ribonuclease inhibitor RI induces a conformational change of RNase 7 as recently reported for the interaction of RNase 1 and the ribonuclease inhibitor [37].
###end p 47
###begin p 48
###xml 258 261 258 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-DeSmet1">[7]</xref>
###xml 263 267 263 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Pazgier1">[38]</xref>
###xml 269 273 269 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Selsted1">[39]</xref>
###xml 462 466 462 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Powers1">[40]</xref>
###xml 627 640 627 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P. aeruginosa</italic>
###xml 830 834 830 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Huang1">[34]</xref>
###xml 947 951 947 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Powers1">[40]</xref>
###xml 1022 1032 1022 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. faecium</italic>
###xml 75 80 <span type="species:ncbi:9606">human</span>
###xml 627 640 <span type="species:ncbi:287">P. aeruginosa</span>
###xml 1022 1032 <span type="species:ncbi:1352">E. faecium</span>
RNase 7 is a highly cationic protein with a pI of approximately 10.7. Many human antimicrobial proteins are cationic and contain a large number of basic amino acids. Examples comprise the alpha- and beta-defensins, the cathelicidins as well as the histatins [7], [38], [39]. It is believed that the highly cationic character of these molecules results in a high affinity to the negatively charged surface of bacteria, which is prerequisite for efficient killing [40]. Very recently, Huang and colleagues showed by NMR and mutagenesis studies that cationic lysines are critical for the antimicrobial activity of RNase 7 against P. aeruginosa. They suggested that RNase 7 may bind to the negatively charged components of the bacterial membrane through the presence of cationic residues which ultimately leads to membrane disruption [34]. It remains to be shown whether this killing mechanism, which has been proposed for many antimicrobial peptides [40], is also responsible for the high killing activity of RNase 7 against E. faecium.
###end p 48
###begin p 49
###xml 91 101 91 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. faecium</italic>
###xml 91 101 <span type="species:ncbi:1352">E. faecium</span>
In summary, our data suggest that RNase 7 contributes to cutaneous innate immunity against E. faecium and probably other bacteria. An interesting speculation is that dysregulation of RNase 7 may result in higher susceptibility to infectious diseases. A better understanding of the role of endogenous antimicrobial proteins such as RNase 7 may result in the development of novel therapeutic strategies that enhance the cutaneous innate defense system by the application or selective induction of antimicrobial proteins.
###end p 49
###begin title 50
Materials and Methods
###end title 50
###begin title 51
Ethics Statement
###end title 51
###begin p 52
All experiments were performed according to the Declaration of Helsinki protocols and under protocols approved by the Ethics Committee at the Medical Faculty of the Christian-Albrechts-University, Kiel, Germany (A104/06).
###end p 52
###begin title 53
Culture of epithelial cells
###end title 53
###begin p 54
###xml 334 338 334 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Wiedow1">[41]</xref>
###xml 415 416 415 416 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 505 506 505 506 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 511 513 511 513 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
Keratinocytes were derived from foreskin samples obtained from circumcision surgery after obtaining written informed consent. The protocol was approved by the Ethics Committee at the Medical Faculty of the Christian-Albrechts-University, Kiel, Germany. Foreskin-derived primary keratinocytes were isolated from foreskins as described [41] and cultured in Epilife-medium (Sigma) in a humidified atmosphere with 5% CO2. For stimulation experiments, cells were seeded in 12-well tissue culture plates (3.8 cm2⋅well-1, BD Biosciences) and used at 60-80% confluence.
###end p 54
###begin title 55
RNA isolation and cDNA synthesis
###end title 55
###begin p 56
After treatment, cells were washed twice with PBS and harvested using TRIzol reagent (Invitrogen, San Diego, CA) according to the supplier's protocol. RNA quality and quantity were determined by gel electrophoresis and photometry. Subsequently, 1 microg of total RNA was reverse transcribed to cDNA with oligo dT- primers and 50 Units Superscript II (Invitrogen) according to the manufacturer's protocol.
###end p 56
###begin title 57
Real-time PCR
###end title 57
###begin p 58
###xml 237 250 229 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Premix Ex Taq</italic>
###xml 532 534 500 502 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 746 748 684 686 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 1341 1376 1273 1308 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- GGA GTC ACA GCA CGA AGA CCA -3&#8242;</named-content>
###xml 1398 1435 1330 1367 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- CAT GGC TGA GTT GCA TGC TTG A -3&#8242;</named-content>
###xml 1458 1494 1390 1426 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">2 5&#8242;- GCC TCT TCC AGG TGT TTT TG -3&#8242;</named-content>
###xml 1516 1550 1448 1482 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- GAG ACC ACA GGT GCC AAT TT -3&#8242;</named-content>
###xml 1579 1614 1511 1546 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- AGA CGT GAT GAC AAG ATT GAC -3&#8242;</named-content>
###xml 1636 1673 1568 1605 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- TGT CCT TTT TCT CAA AGA CGT C -3&#8242;</named-content>
###xml 1695 1731 1627 1663 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">37 5&#8242;-GGG GCT CCT TTG ACA TCA GT -3&#8242;</named-content>
###xml 1753 1787 1685 1719 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- TGG GTA CAA GAT TCC GCA AA -3&#8242;</named-content>
Real-time PCR analyses were performed in a fluorescence thermal cycler (LightCycler; Roche Diagnostics GMBH). cDNA corresponding to 10 ng RNA served as a template in a 10 microl reaction containing 0.5 microM of each primer and 1 x SYBR Premix Ex Taq mix (TaKaRa). Samples were loaded into capillary tubes and incubated in the fluorescence thermal cycler (LightCycler) for an initial denaturation at 95degreesC for 10 min followed by 45 cycles, each cycle consisting of 95degreesC for 15 s, 60degreesC (touchdown of -1degreesC⋅cycle-1 from 66degreesC to 60degreesC) for 5 s and 72degreesC for 10 s. At the end of each run, melting curve profiles were produced by cooling the sample to 65degreesC for 15 s and then heating slowly at 0.20degreesC⋅s-1 up to 95degreesC with continuous measurement of fluorescence to confirm amplification of specific transcripts. Cycle-to-cycle fluorescence emission readings were monitored and analyzed using LightCycler Software (Roche Diagnostics GMBH). The specificity of the amplification products was further verified by subjecting the amplification products to electrophoresis on a 2% agarose gel. The fragments were visualized by ethidium bromide staining and the specificity of PCR products was verified by sequencing of representative samples. The following intron spanning primers were used: RNase-7 5'- GGA GTC ACA GCA CGA AGA CCA -3' (forward primer) and 5'- CAT GGC TGA GTT GCA TGC TTG A -3' (reverse primer); hBD-2 5'- GCC TCT TCC AGG TGT TTT TG -3' (forward primer) and 5'- GAG ACC ACA GGT GCC AAT TT -3' (reverse primer); psoriasin 5'- AGA CGT GAT GAC AAG ATT GAC -3' (forward primer and )5'- TGT CCT TTT TCT CAA AGA CGT C -3' (reverse primer); LL-37 5'-GGG GCT CCT TTG ACA TCA GT -3' (forward primer) and 5'- TGG GTA CAA GAT TCC GCA AA -3' (reverse primer). Standard curves were obtained for each primer set with serial dilutions of plasmids containing the amplification product. Absolute transcript levels are shown per 10 ng total RNA.
###end p 58
###begin title 59
###xml 37 44 37 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 37 44 <span type="species:ncbi:562">E. coli</span>
Expression of recombinant RNase 7 in E. coli
###end title 59
###begin p 60
###xml 292 299 292 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 707 711 707 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Harder4">[42]</xref>
###xml 944 948 944 948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Harder4">[42]</xref>
###xml 1144 1148 1144 1148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Harder3">[25]</xref>
###xml 292 299 <span type="species:ncbi:562">E. coli</span>
###xml 685 690 <span type="species:ncbi:9606">human</span>
The cDNA encoding the 128 amino acids containing natural form of RNase 7 was cloned into the expression vector pET-32a (Novagen), which contains an N-terminal His-Tag sequence allowing purification of the fusion-protein by the use of a nickel-affinity column. A 200 ml culture of transformed E. coli (strain BL21pLysS, Novagen) was grown to an optical density of 0.6 and expression was induced by adding 1 mM IPTG. Expression was carried out for 3 h and bacteria were harvested by centrifugation at 6000 x g for 5 min and lysed by sonication. Extracts were purified with a nickel-affinity column (Macherey-Nagel) followed by C8 reversed-phase HPLC as described for the purification of human beta-defensin-3 [42]. The N-terminal part of the purified fusion protein was cleaved off by enterokinase (Invitrogen) and the resulting mature 128 amino acids containing RNase 7 protein was purified by C2/C18 reversed phase HPLC as previously described [42]. Mass analysis using electrospray ionization mass spectrometry (QTOF-II Hybrid-mass spectrometer; Micromass) yielded a mass of 14,546 Da, which exactly corresponds to the mass of natural RNase 7 [25].
###end p 60
###begin p 61
###xml 240 317 240 317 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- ACT GAG ATC TGG GTA CCG ACG ACG ACG ACA AGA AGC CCA AGG GCA TGA CCT C -3&#8242;</named-content>
###xml 329 388 329 388 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- ATT TGC GGC CGC CTA AAG GAC TCT GTC CAA GTC TAC AGG -3&#8242;</named-content>
###xml 458 461 458 461 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NOT</italic>
###xml 467 470 467 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bgl</italic>
###xml 712 760 712 760 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- GCA CAC AAA ACG GTG CAG AGA CCT CAA CAC C 3&#8242;</named-content>
###xml 772 821 772 821 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;- GGT GTT GAG GTC TCT GCA CCG TTT TGT GTG C- 3&#8242;</named-content>
###xml 872 879 872 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 872 879 <span type="species:ncbi:562">E. coli</span>
Recombinant RNase 7 without ribonuclease activity was generated by site-directed mutagenesis to introduce mutations in the active center of RNase 7. First, histidin at position 123 was mutated to aspartate using the following primer: sense 5'- ACT GAG ATC TGG GTA CCG ACG ACG ACG ACA AGA AGC CCA AGG GCA TGA CCT C -3', antisense 5'- ATT TGC GGC CGC CTA AAG GAC TCT GTC CAA GTC TAC AGG -3'. The resulting PCR product was digested with the restriction enzymes NOTI and BglII and subsequently cloned into the expression vector pET-32a. This plasmid was used as a template to mutate lysine at position 38 to arginine using the "QuikChange Multi Site-Directed Mutagenesis Kit" (Stratagene) and the following primers: 5'- GCA CAC AAA ACG GTG CAG AGA CCT CAA CAC C 3', antisense 5'- GGT GTT GAG GTC TCT GCA CCG TTT TGT GTG C- 3'. The mutated plasmids were used for expression in E. coli as described above. The correct mass of the resulting protein was verified by electrospray ionization mass spectrometry.
###end p 61
###begin title 62
Generation of RNase 7-specific antibodies
###end title 62
###begin p 63
###xml 974 978 <span type="species:ncbi:9925">goat</span>
###xml 1346 1350 <span type="species:ncbi:9925">goat</span>
0.5 mg natural skin-derived RNase 7 was mixed with 1.3 mg recombinant RNase 7 and the resulting 1.81mg were used for immunization. 1.2 mg of this RNase 7 preparation was conjugated to keyhole limpet hemocyanine (KLH, Sigma) using glutaraldehyde. Therefore, 1 mg KLH in 1 ml PBS was mixed with 1 microl 25% glutaraldehyde (Serva) and incubated for 1 h at room temperature with gently shaking. After incubation, the reaction mixture was diafiltrated and concentrated in 400 microl PBS using a vivaspin 0.5 ml concentrator column (30 kDa cut off, Vivascience). The KLH-glutaraldehyde concentrate (400 microl) was incubated with 600 microl of 1.2 mg RNase 7 in PBS for 1 h at room temperature with gentle rotation. The reaction was stopped by the addition of 5 microl 1 M Tris (pH 8.0). 500 microl of 0.6 mg RNase 7 in PBS was added and the preparation was divided into one 450 microl aliquot for initial immunization and three 350 microl aliquots for booster immunization of a goat. The immunization was carried out by the "ZIKA-Kaninchenbetrieb" (Gottin, Germany). We generated an RNase 7 affinity column to selectively isolate RNase 7 specific antibodies from the serum. Therefore, 1.5 mg of recombinant RNase 7 was coupled to a 1 ml HiTrap NHS-activated column (Amersham Pharmacia Biotech) according to the manufacturer's protocol. 500 microl of goat anti-RNase 7 serum was loaded onto the affinity column and the column was washed with 10 mM sodium phosphate buffer, pH 7.3. Low-affinity antibodies were eluted using 1 M NaCl (pH 7) and high-affinity RNase 7 antibodies were eluted using 200 mM glycine (pH 3), immediately neutralized with 1 M Tris (pH 7.5) and dialfiltered against PBS.
###end p 63
###begin title 64
ELISA
###end title 64
###begin p 65
###xml 171 173 148 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 753 755 710 712 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 865 867 818 820 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 1377 1381 1330 1334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Glser1">[18]</xref>
###xml 1383 1387 1336 1340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Voss1">[43]</xref>
###xml 115 119 <span type="species:ncbi:9925">goat</span>
###xml 262 268 <span type="species:ncbi:9913">bovine</span>
###xml 695 699 <span type="species:ncbi:9925">goat</span>
96-well immunoplates (MaxiSorptrade mark, Nunc) were coated at 37degreesC for 1 h with 50 microl affinity-purified goat anti-RNase 7 antibody diluted 1:1000 to 1 microg⋅ml-1 in 0.05 M carbonate buffer, pH 9.6. Subsequently, wells were blocked with 200 microl 1% bovine serum albumin in PBS for 10 min at room temperature. After washing three times with 200 microl PBS+0.1% Tween 20, 50 microl per well of cell culture supernatants and serial dilutions of natural skin-derived RNase 7 in cell culture medium were incubated for 30 min at room temperature. Plates were washed three times with PBS+0.1% Tween 20 and wells were incubated for 30 min at room temperature with 50 microl of biotinylated goat anti-RNase 7 antibody diluted 1:7500 to 1.3 microg⋅ml-1 in PBS+0.1% Tween 20. Plates were washed again three times with PBS+0.1% Tween and filled with 50 microl⋅well-1 of Streptavidin-POD (Roche Diagnostics; 1:10000 in PBS+0.1% Tween 20). The plates were then incubated for 30 min at room temperature, washed six times as described above, and incubated with the development agent 2,2'-azino-bis-3-ethylbenzthiazoline-6-sulfonic acid (ABTS; Roche Diagnostics) for 15 min at room temperature in the dark. Absorbance was measured at 405 nm with a multichannel photometer (Sunrise; Tecan, Crailsheim, Germany). The psoriasin and hBD-2 ELISAs were performed as previously described [18], [43].
###end p 65
###begin title 66
Western blot
###end title 66
###begin p 67
###xml 136 140 136 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Schrder3">[44]</xref>
###xml 455 457 451 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 548 550 538 540 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 651 653 637 639 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 760 762 746 748 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 835 840 <span type="species:ncbi:10090">mouse</span>
###xml 846 850 <span type="species:ncbi:9925">goat</span>
Stratum corneum derived from the heel of healthy individuals was extracted with acidic ethanolic citrate buffer as previously described [44]. Stratum corneum extract was mixed with 4x NuPAGE LDS Sample Buffer (Invitrogen) and 0.5 microg of this extract was separated onto a NuPAGE 4-12% Bis-Tris Gel (Invitrogen). Proteins were transferred to a Protran-nitrocellulose membrane (Schleicher & Schuell BioScience), blocked for 1 h in blocking buffer (5% (w⋅v-1) nonfat powdered milk in PBS+0.05% Tween), then incubated for 18 h at 4degreesC in 3% (w⋅v-1) nonfat powdered milk in PBS+0.05% Tween containing RNase 7 affinity-purified antibody (10 microg⋅ml-1). The membrane was washed with PBS+0.05% Tween six times for 5 min each, then incubated for 1 h in 3% (w⋅v-1) nonfat powdered milk in PBS+0.05% Tween containing 1:20000 dilution of mouse anti-goat IgG HRP conjugate (Dianova). After another six washes, the membrane was incubated for 5 min with chemiluminescent peroxidase substrate (Sigma) and visualized using a Diana III cooled CCD-camera imaging system (Raytest, Straubenhardt, Germany).
###end p 67
###begin title 68
Immunohistochemistry
###end title 68
###begin p 69
###xml 440 442 436 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 49 54 <span type="species:ncbi:9606">human</span>
###xml 308 314 <span type="species:ncbi:9986">rabbit</span>
###xml 404 408 <span type="species:ncbi:9925">goat</span>
###xml 514 520 <span type="species:ncbi:9986">rabbit</span>
###xml 526 530 <span type="species:ncbi:9925">goat</span>
To localize the protein expression of RNase 7 in human skin biopsies, immunhistochemical staining was performed. Therefore 5 microm vertical paraffin sections were deparaffinised and rehydrated followed by heat-induced antigen retrieval in 0.01 M citrate buffer (pH 6.0). The slides were blocked with normal rabbit serum (1:5, Dako Cytomation) and incubated for 60 min with the self-generated polyclonal goat anti-RNase 7 antibody (10 mg⋅ml-1, 1:400). Subsequently, the sections were incubated with a biotinylated rabbit anti-goat IgG antibody (1:500, Dianova) followed by incubation with Vector Universal ABC Alkaline Phophatase Substrate Kit (Vector), development with Vector NovaRED Substrate (Vector) and counterstaining with hematoxylin. Negative control straining was performed by using preimmune serum.
###end p 69
###begin title 70
Antimicrobial and ribonuclease assay
###end title 70
###begin p 71
###xml 85 89 85 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Harder3">[25]</xref>
###xml 172 176 172 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Rudolph1">[29]</xref>
###xml 347 349 347 349 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
Natural skin-derived RNase 7 was purified from skin extracts as previously described [25] and used for a standard antimicrobial microdilution assay as described previously [29]. Briefly, test organisms were incubated with various concentrations of RNase 7 in 10 mM sodium phosphate buffer (pH 7.4 or the indicated pH conditions) containing 1% (v⋅v-1) trypticase soy broth for 3 h at 37 degreesC. The antibiotic activity of RNase 7 was analyzed by plating serial dilutions of the incubation mixtures and determining the number of colony-forming units (CFUs) the following day.
###end p 71
###begin p 72
###xml 128 132 128 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Harder3">[25]</xref>
###xml 83 88 <span type="species:ncbi:4932">yeast</span>
The ribonuclease activity of recombinant RNase 7 was determined against a standard yeast tRNA substrate as described previously [25].
###end p 72
###begin title 73
Antimicrobial activity of stratum corneum extracts
###end title 73
###begin p 74
###xml 99 103 99 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006424-Schrder3">[44]</xref>
###xml 256 266 252 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. faecium</italic>
###xml 283 284 279 280 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 476 478 460 462 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 256 266 <span type="species:ncbi:1352">E. faecium</span>
###xml 559 563 <span type="species:ncbi:9925">goat</span>
Stratum corneum derived from the heel of healthy individuals was extracted as previously described [44] and diafiltered against 10 mM sodium phosphate buffer (pH 7.4). ELISA analysis revealed concentrations of 7-63 microg RNase 7 per gram stratum corneum. E. faecium (ATCC 6057; 4x103/ml) was incubated with 1 microl of stratum corneum in 50 microl 10 mM sodium phosphate buffer (pH 7.4). The same experiment was carried out with application of 10 microl R7 antibody (10 mg⋅ml-1) or equivalent concentrations of irrelevant antibodies (antibodies derived from goat preimmune serum). Killing activity was analyzed by plating serial dilutions of the incubation mixture and counting the colony-forming units (CFU) the following day.
###end p 74
###begin p 75
We thank J. Quitzau, K. Schultz, H. Hinrichs, E. Jeske, C. Wilgus, D. Scharinger, M. Brandt, C. Butzeck-Mehrens, S. Voss for excellent technical assistance and Grace Chen for help with the manuscript.
###end p 75
###begin title 76
References
###end title 76
###begin article-title 77
Cutaneous defense mechanisms by antimicrobial peptides.
###end article-title 77
###begin article-title 78
###xml 26 31 <span type="species:ncbi:9606">human</span>
Antimicrobial peptides in human skin.
###end article-title 78
###begin article-title 79
Antimicrobial skin peptides and proteins.
###end article-title 79
###begin article-title 80
The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection.
###end article-title 80
###begin article-title 81
Innate antimicrobial peptide protects the skin from invasive bacterial infection.
###end article-title 81
###begin article-title 82
###xml 44 59 <span type="species:ncbi:10090">transgenic mice</span>
###xml 73 78 <span type="species:ncbi:9606">human</span>
Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin.
###end article-title 82
###begin article-title 83
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human antimicrobial peptides: defensins, cathelicidins and histatins.
###end article-title 83
###begin article-title 84
Antimicrobial peptides of multicellular organisms.
###end article-title 84
###begin article-title 85
Cathelicidins, multifunctional peptides of the innate immunity.
###end article-title 85
###begin article-title 86
The role of cathelicidins in the innate host defenses of mammals.
###end article-title 86
###begin article-title 87
IL-22 increases the innate immunity of tissues.
###end article-title 87
###begin article-title 88
###xml 0 22 <span type="species:ncbi:287">Pseudomonas aeruginosa</span>
###xml 59 64 <span type="species:ncbi:9606">human</span>
Pseudomonas aeruginosa- and IL-1beta-mediated induction of human beta-defensin-2 in keratinocytes is controlled by NF-kappaB and AP-1.
###end article-title 88
###begin article-title 89
###xml 57 62 <span type="species:ncbi:9606">Human</span>
Differential Regulation of {beta}-Defensin Expression in Human Skin by Microbial Stimuli.
###end article-title 89
###begin article-title 90
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human beta-defensin-2.
###end article-title 90
###begin article-title 91
Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus.
###end article-title 91
###begin article-title 92
The antimicrobial peptide LL-37 is expressed by keratinocytes in condyloma acuminatum and verruca vulgaris.
###end article-title 92
###begin article-title 93
###xml 58 63 <span type="species:ncbi:9606">human</span>
Psoriatic scales: a promising source for the isolation of human skin-derived antimicrobial proteins.
###end article-title 93
###begin article-title 94
###xml 42 47 <span type="species:ncbi:9606">human</span>
###xml 58 74 <span type="species:ncbi:562">Escherichia coli</span>
Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection.
###end article-title 94
###begin article-title 95
The RNase a superfamily: generation of diversity and innate host defense.
###end article-title 95
###begin article-title 96
Eosinophil cationic protein/RNase 3 is another RNase A-family ribonuclease with direct antiviral activity.
###end article-title 96
###begin article-title 97
###xml 12 17 <span type="species:ncbi:9606">human</span>
###xml 106 133 <span type="species:ncbi:12814">respiratory syncytial virus</span>
Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus.
###end article-title 97
###begin article-title 98
Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein.
###end article-title 98
###begin article-title 99
Angiogenins: a new class of microbicidal proteins involved in innate immunity.
###end article-title 99
###begin article-title 100
###xml 73 78 <span type="species:ncbi:9606">human</span>
Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells.
###end article-title 100
###begin article-title 101
###xml 72 77 <span type="species:ncbi:9606">human</span>
RNase 7, a novel innate immune defense antimicrobial protein of healthy human skin.
###end article-title 101
###begin article-title 102
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human RNase 7: a new cationic ribonuclease of the RNase A superfamily.
###end article-title 102
###begin article-title 103
###xml 67 72 <span type="species:ncbi:9606">human</span>
UV-B radiation induces the expression of antimicrobial peptides in human keratinocytes in vitro and in vivo.
###end article-title 103
###begin article-title 104
Differential mRNA expression of antimicrobial peptides and proteins in atopic dermatitis as compared to psoriasis vulgaris and healthy skin.
###end article-title 104
###begin article-title 105
###xml 37 42 <span type="species:ncbi:9606">human</span>
Identification of RNase 8 as a novel human antimicrobial protein.
###end article-title 105
###begin article-title 106
Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens.
###end article-title 106
###begin article-title 107
Eosinophils, ribonucleases and host defense: solving the puzzle.
###end article-title 107
###begin article-title 108
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human hair follicle epithelium has an antimicrobial defence system that includes the inducible antimicrobial peptide psoriasin (S100A7) and RNase 7.
###end article-title 108
###begin article-title 109
###xml 12 17 <span type="species:ncbi:9606">human</span>
Recombinant human eosinophil cationic protein. Ribonuclease activity is not essential for cytotoxicity.
###end article-title 109
###begin article-title 110
###xml 46 51 <span type="species:ncbi:9606">human</span>
The flexible and clustered lysine residues of human ribonuclease 7 are critical for membrane permeability and antimicrobial activity.
###end article-title 110
###begin article-title 111
###xml 80 93 <span type="species:ncbi:9031">Gallus gallus</span>
Evolution and function of leukocyte RNase A ribonucleases of the avian species, Gallus gallus.
###end article-title 111
###begin article-title 112
Degradation by Stratum Corneum Proteases Prevents Endogenous RNase Inhibitor from Blocking Antimicrobial Activities of RNase 5 and RNase 7.
###end article-title 112
###begin article-title 113
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 51 56 <span type="species:ncbi:9606">human</span>
Inhibition of human pancreatic ribonuclease by the human ribonuclease inhibitor protein.
###end article-title 113
###begin article-title 114
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human beta-defensins.
###end article-title 114
###begin article-title 115
Mammalian defensins in the antimicrobial immune response.
###end article-title 115
###begin article-title 116
The relationship between peptide structure and antibacterial activity.
###end article-title 116
###begin article-title 117
###xml 21 26 <span type="species:ncbi:9606">human</span>
Antileukoprotease in human skin: an antibiotic peptide constitutively produced by keratinocytes.
###end article-title 117
###begin article-title 118
###xml 34 39 <span type="species:ncbi:9606">human</span>
###xml 66 71 <span type="species:ncbi:9606">human</span>
Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic.
###end article-title 118
###begin article-title 119
###xml 60 65 <span type="species:ncbi:9606">human</span>
NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2.
###end article-title 119
###begin article-title 120
Neutrophil-activating proteins in psoriasis.
###end article-title 120
###begin p 121
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 121
###begin p 122
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This study was supported by Deutsche Forschungsgemeinschaft (SFB 617 and a Heisenberg program given to J.H.) as well as by the Federal Ministry of Education and Research (BMBF; BioChancePlus). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 122

